Generics Global Group of Eight (G8) Industry Guide_2017

Generics Global Group of Eight (G8) Industry Guide_2017 Cover

Single Licence: $1495

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
160
Pharmaceuticals and Healthcare
G8

Generics Global Group of Eight (G8) Industry Guide_2017

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the G8 generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies. – The G8 countries contributed $189.4 billion in 2016 to the global generics industry, with a compound annual growth rate (CAGR) of 10.9% between 2012 and 2016. The G8 countries are expected to reach a value of $384.0 billion in 2021, with a CAGR of 15.2% over the 2016-21 period. – Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $99.7 billion in 2016. This was followed by Japan and Germany, with a value of $56.6 and $8.5 billion, respectively. – Japan is expected to lead the generics industry in the G8 nations with a value of $199.9 billion in 2016, followed by the US and the UK with expected values of $141.2 and $12.1 billion, respectively.

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 generics market – Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market – Leading company profiles reveal details of key generics market players’ G8 operations and financial performance – Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume – Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to buy

– What was the size of the G8 generics market by value in 2016? – What will be the size of the G8 generics market in 2021? – What factors are affecting the strength of competition in the G8 generics market? – How has the market performed over the last five years? – Who are the top competitors in the G8 generics market? 

Request more information (Table of Contents, List of table, List of Figures) by using the form below:

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $1495

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.